[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646462":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":28,"centralContacts":32,"locations":42,"responsibleParty":61,"collaborators":63,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":10,"eligibilityCriteria":72,"healthyVolunteers":69,"sex":73,"minAge":74,"maxAge":10,"enrollmentInfo":75,"targetDuration":10,"studyType":78,"phases":10,"briefSummary":79,"conditions":80,"keywords":84,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Men with prostate cancer",null,"Participants who have planned or completed a non-investigational radical prostatectomy will be asked to complete a series of questionnaires online covering a subset of community-informed SSDH measures and individual exposures. Responses will be recorded in a secured database. . It will take about up to 2 hours to complete the surveys. There will be questions about your demographics (education level, income, employment, etc.); health care access and quality; lifestyle and behaviors. Data from your medical record about your prostate cancer and treatment will also be collected.",[13,14],"Other: Questionnaires","Other: Medical Record Review",[16,22],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"Questionnaires","Participants will receive surveys to complete online via a secure system.",[9],[21],"Surveys",{"type":6,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"Medical Record Review","Data will be collected from participants medical charts which includes disease history, pathological findings, and other disease characteristics.",[9],[27],"Medical Chart Review",[29],{"name":30,"affiliation":5,"role":31},"Matthew Cooperberg, MD","PRINCIPAL_INVESTIGATOR",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},"Kiana Washington","CONTACT","415.514.8026","Kiana.Washington@ucsf.edu",{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},"Karina Acevedo","415.353.7615","Karina.Acevedo@ucsf.edu",[43],{"facility":5,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","San Francisco","California","94143","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-122.41942,37.77493,{"lat":54,"lon":53},[57,58,59],{"name":34,"role":35,"phone":36,"phoneExt":10,"email":37},{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},{"name":60,"role":31,"phone":10,"phoneExt":10,"email":10},"Mathew Cooperberg, MD, MPH",{"type":62,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[64],{"name":65,"class":66},"National Cancer Institute (NCI)","NIH","100646462","social-structural-and-lifestyle-drivers-of-prostate-cancer-disparities-100646462",false,"NCT07690579","Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities","Inclusion Criteria:\n\n* Participants who have elected radical prostatectomy as prostate cancer treatment.\n* Participants who have agreed to participate in the Urology Biobank.\n\nExclusion Criteria:\n\n* Participant does not plan nor schedule a radical prostatectomy (RP) procedure.","MALE","18 Years",{"count":76,"type":77},350,"ESTIMATED","OBSERVATIONAL","Prostate Cancer (PC) is the most common non-cutaneous malignancy diagnosed and second leading cause of cancer death among men across the United States. PC among Black men accounts for a higher proportion alike of cancer diagnoses and deaths. In the prostate specific antigen (PSA)-based screening era, mortality rates improved at a similar velocity among Black and White men, but the 2- to 3-fold excess mortality burden borne by Black men has persisted over the past 40 years, the second highest among all major cancers. In recent years mortality is rising among Black men, and at a rapid velocity.\n\nThe explanations for this disparity-the extent to which it is attributable to genetics, environmental factors including Structural and Social Determinants of Health (SSDH), or access to care-are multifactorial and have been elucidated to a limited extent. A large meta-analysis recently found that across dozens of studies and cohorts, greater adjustment for clinical and SSDH factors generally resulted in race itself dropping as a significant predictor.\n\nThese and other findings suggest that the determinants of disparity be identified at time of, and prior to, cancer diagnosis, and that both genetic and environmental factors contribute to earlier development and progression.",[81,82,83],"Prostate Cancer","Prostate Cancer Recurrent","Prostate Metastases",[85],"Radical Prostatectomy","2026-07-01",{"date":88,"type":89},"2026-07-08","ACTUAL",{"date":91,"type":89},"2026-03-31",{"date":93,"type":77},"2028-03-31",{"name":5,"class":6},1]